Published in:
Open Access
01-02-2011 | Poster presentation
Pharmacological CCR1 blockade limits infarct size and preserves cardiac function in a chronic model of myocardial ischemia/reperfusion
Authors:
A Van de Sandt, S Zander, S Becher, R Ercan, C Quast, J Ohlig, T Lauer, T Rassaf, M Kelm, MW Merx
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
This study sought to determine the chronic effects of pharmacological blockade of the chemokine receptor CCR1 via application of the potent, selective antagonist BX471 in a murine model of myocardial ischemia/reperfusion (I/R). CCR1 is a prominent receptor in mediating inflammatory leukocyte recruitment. The intense inflammatory response is considered to be a key component of cardiac remodelling. Thus, limiting the post-reperfusion inflammatory pattern seems to be a promising therapeutic approach in limiting reperfusion injury. Previously, we demonstrated that CCR1-/- mice exhibit attenuated infarct expansion and preserved LV function in a chronic model of myocardial no-reflow infarction due to an abrogated inflammatory response. …
